Keyphrases
Alzheimer's Disease Treatment
100%
Stem Cell Lines
100%
Human Stem Cells
100%
Clinical Trials
50%
Alzheimer's Disease
50%
Alternative Therapy
50%
Neural Stem Cells
50%
Pharmacological Treatment
50%
Neurodegenerative Diseases
50%
Primary Culture
50%
Phase I Trial
50%
Alzheimer's Disease Patient
50%
Phosphorylated tau
50%
Disease-modifying Therapy
50%
Toxic Effects
50%
Amyloid-β Peptide
50%
Alzheimer's Disease Pathology
50%
Cell Viability Assay
50%
Okadaic Acid
50%
Concentration Dependence
50%
Clinical Grade
50%
Condition-dependent
50%
People with Stroke
50%
Rat Neural Stem Cells
50%
Phosphatase 2A
50%
Large-scale Clinical Trial
50%
Medicine and Dentistry
Combination Therapy
100%
Alzheimer's Disease
100%
Stem Cell Line
100%
Cell Line
75%
Clinical Trial
50%
Neural Stem Cell
50%
Disease
25%
Apoplexy
25%
Drug Therapy
25%
Neurodegenerative Disorder
25%
Primary Culture
25%
Amyloid
25%
Toxicity
25%
Phosphatase
25%
Phase I Trials
25%
Cell Viability Assay
25%
Tau
25%
Okadaic Acid
25%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Alzheimer's Disease
100%
Clinical Trial
50%
Disease
50%
Primary Culture
25%
Phase I Trials
25%
Phosphatase
25%
Amyloid
25%
Cell Viability
25%
Toxicity
25%
Okadaic Acid
25%
Viability Assay
25%
Neuroscience
Alzheimer's Disease
100%
Stem Cell
100%
Cell Line
100%
Neural Stem Cell
40%
Amyloid
20%
Phosphatase
20%
Neurodegenerative Disorder
20%
Primary Culture
20%
Cell Viability
20%
Okadaic Acid
20%